To healthcare providers and patients:

In response to the spread of the COVID-19 virus, IBSA would like to reassure you about the safety and availability of our products. Both Tirosint and Tirosint-SOL are:

  • Made in our state-of-the-art production facility in Switzerland. No ingredients are sourced from Asian suppliers
  • Currently in stock and available. No shortages or interruption of supply are anticipated
  • Available in retail pharmacies and via Tirosint Direct, a convenient direct mail pharmacy service that delivers your prescription to your home within 2-3 days after your order has been processed. The Tirosint Direct Program stocks all doses of Tirosint and Tirosint-SOL and offers the lowest out-of-pocket cost for patients regardless of their insurance coverage. For more information about Tirosint Direct, please visit or

Healthcare professionals can contact IBSA’s Medical Information line for customer service, patient assistance information, product information and adverse event reporting. Please call 1-800-587-3513.

Healthcare professionals can contact their local IBSA sales representative for samples and patient support materials.